Patents
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
11/2008
11/06/2008WO2008132679A1 Bridged six-membered ring compounds
11/06/2008WO2008132128A2 Synthesis of a pharmaceutically active compound
11/06/2008US20080275272 Amine compounds and inhibiting neurotransmitter reuptake
11/06/2008US20080274924 Method for producing mannich adducts that contain polyisobutylene phenol
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/05/2008EP1987013A1 Bicyclic sphingosine 1-phosphate analogs
11/05/2008EP1986996A2 A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
11/05/2008EP1986992A1 Process for preparing dihydroxytrialkylammonium halides and products thereof
11/05/2008EP1986636A2 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
11/05/2008EP1490325B1 Manufacture of phenyl ethylamine compounds, in particular venlafaxine
11/05/2008CN101300223A Alkylamino alkyloxy (alcohol) monoalkyl ether for acid gas scrubbing process
11/05/2008CN101298050A Method for preparing alpha-alkamine using alpha-aminoacid as raw material and used catalyst and preparation of catalyst
11/05/2008CN100430369C Hydroxy aromatic mannich base condensation products and use thereof as soot dispersants in lubricating oil compsns.
11/04/2008US7446226 Phenylhept-6-yne-acid-4-hydroxy-3-methoxylbenzylamide (phenylcapsaicin); use as microorganism repellent agents in paints and coatings, for marine installations and ships, but also for land-based structures; nontoxic
11/04/2008US7445771 1,3-bis[(dimethyl,hydroxymethyl) methylamino]propane; antiseptic and disinfectant; preventing microbial contamination; multi-functional component for contact lens solution and multi-dose ophthalmic compositions
10/2008
10/30/2008WO2008064320A3 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
10/29/2008EP1984321A1 Methods for preparing sulfonamide substituted alcohols and intermediates thereof
10/23/2008US20080261895 Central nervous system disorders
10/22/2008EP1982985A2 Method for manufacturing a purine derivative
10/22/2008CN101291665A Naphthyl derivatives as inhibitors of beta-amyloid aggregation
10/21/2008US7439400 Amino alcohol ligand and its use in preparation of chiral proparglic tertiary alcohols and tertiary amines via enantioselective addition reaction
10/21/2008US7439397 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis
10/16/2008WO2008124097A2 Salts of isophosphoramide mustard and analogs thereof
10/16/2008WO2008123821A1 4, 5-dihydro-lh-imidazol-2-amine derivatives for use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
10/16/2008US20080255089 Menopausal or postmenopausal disorders, vasomotor symptoms, urogenital disorders, female sexual dysfunction, breast cancer, depression, diabetes, bone demineralization, and osteoporosis; substituted 2-(p-aminoalkoxyphenyl)-1,1-diphenylethylene derivatives
10/16/2008CA2684747A1 Salts of isophosphoramide mustard and analogs thereof
10/15/2008EP1978961A2 Tetralone-based monoamine reuptake inhibitors
10/15/2008EP1810963B1 Fluorine-containing polymerizable monomer and polymer compound using same
10/15/2008EP0923544B1 Method for the synthesis of amines and amino acids with organoboron derivatives
10/14/2008US7435854 Reacting venlafaxine with a high molecular weight alkyl, arylalkyl or aryl mercaptan anion (which may be generated by a metal alkoxide) in an alcohol or ether solvent; time and material efficient
10/09/2008WO2008120475A1 Method for producing alcohol by hydrogenating lactone and carboxylic acid ester in liquid phase
10/09/2008WO2008064337A3 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
10/09/2008US20080249070 potent, and selective agonists for G protein-coupled receptors (S1P1); to treat autoimmune diseases, such as, uveitis, type I diabetes, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, cancer, neurodegenerative diseases; (1-amino-3-(4-octylphenyl cyclopentyl)methanol
10/09/2008US20080248584 Trityl derivatives for enhancing mass spectrometry
10/08/2008EP1444193B1 Process for the preparation of tertiary amines from primary amines and nitriles
10/08/2008CN101281266A Filter for electronic display
10/08/2008CN101281265A Filter for electronic display
10/08/2008CN101279924A Preparation of high-purity 4,6-diamino-resorcin or hydrochlorate thereof
10/08/2008CN100424135C Colorants produced by reaction of oxyalkylene-substituted aminophenol intermediate
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432228 Applying a N-aryl(methyl)-p-hydroxy- or p-alkoxy--phenylalkylamine, e.g., 4-[2-(2-hydroxy-benzylamino)-ethyl]-phenol to inhibit 9-cis-epoxycarotenoid dioxygenase; plant growth regulators
10/02/2008WO2008117704A1 3,3'-diamino-5,5'-diphenyl-4,4'-biphenyldiol, raw material therefor, and polybenzoxazole
10/01/2008EP1973866A1 Process for making desvenlafaxine
10/01/2008CN101277929A Method of obtaining phenyl carbamates
10/01/2008CN101277926A Method of obtaining 3,3-diphenylpropylamines
10/01/2008CN101274926A Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
10/01/2008CN101274898A Process for 4- amino-3-fluorophenol
10/01/2008CN101274897A Crystalline polymorphs of desvenlafaxine succinate and their preparations
10/01/2008CN100422139C 氨基链烷醇衍生物 Amino alkanol derivative
09/2008
09/25/2008WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
09/25/2008US20080234281 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer
09/24/2008CN101270058A Process for preparing 3-(1-dimethylamino- ethyl)phynol
09/23/2008US7427678 Reacting a derivatized molecule with a support; diels-alder reaction; fluorescein; diene or dienophile
09/23/2008US7427639 β2-adrenergic receptor agonists
09/18/2008WO2008112313A2 Processes for preparing solid states of o-desmethylvenlafaxine succinate
09/18/2008WO2008111563A1 Process for production of optically active sulfoxide compound using iron-salan complex catalyst
09/18/2008WO2008110338A1 Polymorph of desvenlafaxine succinate
09/18/2008WO2008070496A3 N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
09/18/2008US20080227981 Charge transport compositions and electronic devices made with such compositions
09/18/2008US20080227859 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/17/2008CN101265199A Method for the preparation of escitalopram
09/17/2008CN101265198A Method for preparing tri-isopropanolamine
09/17/2008CN101265197A Method for preparing diisopropanolamine
09/17/2008CN101265196A Method of synthesizing monoisopropanolamine
09/17/2008CN101265195A Method for preparing N-methyldiethanolamine
09/12/2008WO2008090465A3 Process for synthesizing desvenlafaxine free base and salts or salvates thereof
09/11/2008US20080221361 Ionic Liquids
09/10/2008EP1966127A1 Carbonyl asymmetric alkylation
09/10/2008CN101260051A Biodegradable choline-like ionic liquid
09/10/2008CN101260050A 氨基链烷醇衍生物 Amino alkanol derivative
09/10/2008CN101259414A Catalyst for p-nitrophenol hydrogenation to prepare p-aminophenol and preparation thereof
09/09/2008US7423180 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof
09/09/2008US7423035 e.g. 5-hydroxy-8-{1-hydroxy-2-[1-(4-methoxy-benzyl)-cyclopropylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one; mimetics of beta-adrenergic substances; beta 2-adrenoceptor modulator; antiinflammatory agent; chronic obstructive respiratory diseases; longer duration of activity
09/09/2008CA2412047C Shortened synthesis of 3,3-diarylpropylamine derivatives
09/04/2008US20080214849 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium
09/04/2008DE112006001701T5 Verfahren zur Herstellung von optisch aktiven Benzylaminderivaten A process for the preparation of optically active benzylamine derivatives
09/03/2008CN101255118A Method for preparing beet alkali hydrochlorate
09/02/2008US7420003 Compounds and a novel process for their preparation
09/02/2008CA2230826C Galanthamine derivatives and process for their preparation
09/02/2008CA2220436C Liquid rheological additives providing rheological properties to non-aqueous systems and non-aqueous systems containing such liquid rheological additives
08/2008
08/28/2008WO2008103461A2 Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof
08/28/2008WO2008017278B1 Crystalline tolterodine tartarate and a pharmaceutical composition containing the same
08/28/2008US20080207898 Processes for the preparation of aminoethoxybenzyl alcohols
08/28/2008US20080207735 1-Amino Linked Compounds
08/28/2008US20080207725 Skin disorders; antiinflamamtory agenst; antiallergens
08/27/2008CN101250118A Method for preparing 4,6-diaminoresorcinol hydrochloride
08/27/2008CN101250117A Method for preparing 2,2-di(3-amino-4-hydroxy phenyl) propane
08/27/2008CN101250116A Method for suppressing impurity substance during preparation of benzo ammonia alcohol
08/27/2008CN101250115A Method for synthesizing 3-amido-1,2-propanediol by pipe reactor
08/26/2008US7417170 Such as 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol; hydrogenation
08/26/2008US7416868 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth
08/21/2008WO2008099730A1 Method for production of amine compound using optically active 2-(aroyloxy)propionic acid
08/21/2008US20080200556 Amine Compounds And Inhibiting Neurotrasmitter Reuptake
08/20/2008EP1957440A1 Process for preparing 3-amino-3-methyl-1-butanol
08/19/2008US7414162 Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers
08/19/2008US7414157 Hydroxylation of β-dicarbonyls with zirconium catalysts
08/19/2008US7414154 polyamine compound is administered locally to provide protection against the adverse side-effects of chemotherapy or radiation therapy
08/19/2008US7414153 1-1-phenyl-1-hydroxy-2-propanone, which comprises converting 1-1-phenyl-1-hydroxy-2-propanone to 1-1-phenyl-1-hydroxy-2-propanone oxime and reducing the oxime with a catalyst consisting of finely divided nickel and aluminium metals giving good diastereomeric purity and yield
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 116